Literature DB >> 10530452

Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus.

M Hall1, L Hoyt, P Ferrieri, P M Schlievert, H B Jenson.   

Abstract

Two children had symptoms and clinical signs that were characteristic of the diagnostic criteria for Kawasaki syndrome, temporally associated with Staphylococcus aureus bacteremia. One child initially had focal osteomyelitis that was evident clinically and radiographically, and radiographic evidence of multifocal osteomyelitis was noted at follow-up. The blood-borne S. aureus isolates from these two patients secreted staphylococcal enterotoxin B and were negative for toxic shock syndrome toxin. Staphylococcal and streptococcal superantigens may play a role in the pathogenesis of some cases of Kawasaki syndrome or Kawasaki syndrome-like illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530452     DOI: 10.1086/598638

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Osteomyelitis in Kawasaki disease.

Authors:  Satya Prakash Singh; Nasir Husain Ansari; Yashwant Singh Tanwar; Masood Habib
Journal:  Indian J Pediatr       Date:  2014-05-02       Impact factor: 1.967

3.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

Review 4.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Mycoplasma pneumoniae infection in patients with Kawasaki disease.

Authors:  Mi Na Lee; Jie Hae Cha; Hye Mi Ahn; Jeong Hyun Yoo; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2011-03-31

6.  Kawasaki disease associated with Mycoplasma pneumoniae.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Jie Huang; Weiguo Qian; Miao Hou; Haitao Lv
Journal:  Ital J Pediatr       Date:  2016-09-08       Impact factor: 2.638

Review 7.  Pathogenetic determinants in Kawasaki disease: the haematological point of view.

Authors:  Domenico Del Principe; Donatella Pietraforte; Lucrezia Gambardella; Alessandra Marchesi; Isabella Tarissi de Jacobis; Alberto Villani; Walter Malorni; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2017-01-07       Impact factor: 5.310

8.  Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.

Authors:  Kazuya Shirato; Yoshio Imada; Miyuki Kawase; Keiko Nakagaki; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Med Virol       Date:  2014-04-24       Impact factor: 2.327

9.  Adult-onset Kawasaki disease (mucocutaneous lymph node syndrome) and concurrent Coxsackievirus A4 infection: a case report.

Authors:  Yuki Ueda; Tsuneaki Kenzaka; Ayako Noda; Yu Yamamoto; Masami Matsumura
Journal:  Int Med Case Rep J       Date:  2015-09-29

10.  Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis.

Authors:  Mitchell S von Itzstein; Jithma P Abeykoon; Daniel D Summerfield; Jennifer A Whitaker
Journal:  BMJ Case Rep       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.